Pathogenomix

Advanced sequencing analysis with Pathogenomix RipSeq online easy-to-use software. Any sequence, no All you need is an internet browser.

Infection Intelligence

RipSeq sequence-based analysis reduces the time needed to identify infectious pathogens, in pure- or poly-microbial samples, by up to 90% - and provides answers where other methods fail. Use any sequencing technology you want - Ripseq is platform agnostic. Combined with Ripseq DB, this is complete SaaS diagnostic solution, able to identify pathogens more accurately, faster

08/07/2023

Great new article using targeted NGS in the clinic:
Pleural Empyema Caused by Streptococcus intermedius and Fusobacterium nucleatum: A Distinct Entity of Pleural Infections
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad378/7205386

01/19/2022

Santa Cruz, CA: January 19th 2022 – Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho-Seq assay.

https://pathogenomix.com/pathogenomix_newsroom.aspx

04/30/2021

Great, new articles on Sanger use in the clinical lab!

04/29/2021

Great new articles on the use of NGS in clinical infections.

03/01/2021

Great article from Mayo Clinic showing the potential for using a broad-range bacterial detection approach for diagnosis of tick-borne bacterial infection from blood. Our Ripseq NGS performed great! Time to give it a try?

https://jcm.asm.org/content/early/2021/02/19/JCM.03129-20

Superinfections and Coinfections in COVID-19

06/11/2020

Great article on the risk of secondary infections during the pandemic. Correct pathogen ID is crucial.

Superinfections and Coinfections in COVID-19 Separating the signal from the noise

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

03/26/2020

Wuhan, China patients pre Jan 31st 2020: "Half of non-survivors experienced a secondary infection":

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interve...

10/23/2019

Great new article on comparing NGS to culture.
https://www.journalofinfection.com/article/S0163-4453(19)30286-5/pdf
Contact us for a free trial of Ripseq NGS!

07/25/2019

New article using Ripseq Sanger on PCR positive and culture negative samples.

https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4271-1?optIn=false

More articles here:
https://www.pathogenomix.com/pathogenomix_ripseq_literature.aspx

07/22/2019

Check out our latest articles on pathogen ID in the clinic. 14 days trial + hands-on demo for free!

Information about RipSeq bacterial identification- Articles and more Rapid Direct Sequencing Analysis of Clinical Samples using NGS or Sanger. Less than 5 minutes analysis time. No bioinformatics resources needed.